Below are the earnings highlights for Protalix BioTherapeutics Inc. (PLX):
Earnings: $19.34 million in Q2 vs. -$5.33 million in the same period last year.
EPS: $0.21 in Q2 vs. -$0.11 in the same period last year.
Revenue: $35.08 million in Q2 vs. $8.75 million in the same period last year.
For comments and feedback: editorial@rttnews.com